SKYE · ISSUER CIK 1516551
Skye Bioscience, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Skye Bioscience, Inc. insiders reported $0.00 of open-market purchases and $609K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 6 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$609KInsider selling
−$609KNet open-market
Sep 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:31 | Sep 23, 2026from Sep 22, 2026 | SKYE | Director, 10% Owner | S · Sell | $1.62 | −148,079 | 0 | -100% | −$240K | ||
| Sep 24, 202616:29 | Sep 23, 2026from Sep 22, 2026 | SKYE | 10% Owner · +7 joint | S · Sell | $1.62 | −148,079 | 0 | -100% | −$240K | ||
| Sep 18, 202618:39 | Sep 16, 2026 | SKYE | Director, 10% Owner | S · Sell | $1.91 | −33,892 | 5,616 | -86% | −$65K | ||
| Sep 18, 202618:37 | Sep 16, 2026 | SKYE | 10% Owner · +7 joint | S · Sell | $1.91 | −33,892 | 5,616 | -86% | −$65K | ||
| Aug 20, 202617:59 | Aug 20, 2026from Aug 18, 2026 | SKYE | Director, 10% Owner | S · SellPrice unverified | $0.37 | −375,840 | 7,850,155 | -5% | — | ||
| Aug 20, 202617:57 | Aug 20, 2026from Aug 18, 2026 | SKYE | 10% Owner · +7 joint | S · SellPrice unverified | $0.37 | −375,840 | 7,850,155 | -5% | — | ||
| Aug 7, 202617:37 | Aug 7, 2026 | SKYE | Chief Executive Officer, Director | A · Grant | — | +1,090,000 | 1,419,823 | +330% | — |